Bayer Group in India and Pfizer India, announced a strategic marketing alliance for animal health products in India, bringing together two of the innovative animal health care companies in the world. With this alliance, Pfizer India's animal health sales force will now market Bayer's international range of livestock products and companion animal health products. Globally, Pfizer is the leader both in human pharmaceuticals as well as the animal health business.

This arrangement will combine two very strong and complimentary product portfolios with an unprecedented therapeutic reach in all segments of the animal healthcare business. Through this alliance, in addition to Pfizer's existing portfolio, a broad range of products from Bayer will be introduced in the livestock, poultry and companion animal segments, among them being Bayticol Pour-on, Drontal Plus Tablets, Bayrocin 10 per cent Injectable, Baycox 2.5 Oral Solution, Negasunt Powder

Stephan Gerlich, country speaker, Bayer Group in India and Hocine Sidi Said, managing director, Pfizer India in Mumbai, signed this agreement.

Speaking on the occasion, Praveen Singh, head - Bayer healthcare said, "Bayer, which is ranked among the top five companies in animal health worldwide, has a presence in the companion animals and livestock segments in India. Through this arrangement, Bayer will be able to introduce the latest products and application technology, which will benefit the Indian Animal Health industry."

Sidi Said, managing director, Pfizer India said that, " It is a win-win situation for both companies. The value of the combined portfolio will be enhanced through the Pfizer field force, which is regarded as one of the best in the industry, and well respected by veterinarians."

In India, Bayer has a diversified business, including agrochemicals and pharmaceuticals and has production facilities at 14 sites. With its above-average growth potential, India is one of Bayer's promising markets in the Asia-Pacific region.

Pfizer India is one of the country's leading pharmaceutical companies and a subsidiary of Pfizer Inc., the world's premier research-based pharmaceutical company.